Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
15 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Please“
Suchtreffer
Begriffe & Kennungen
Aubagio · 4.8 · a : please refer to the detailed description section b : see section 4.4 c : frequency is “common” in children
Eintrag öffnenAvastin · 4.8 · a For further information please refer to Table 3 'Adverse reactions reported in post-marketing setting.' b Te
Eintrag öffnenAwiqli · 4.8 · For information on daily basal insulin comparators used in each trial, please see section 5.1.
Eintrag öffnenBeromun · 4.3 · Please refer to the Summary of Product Characteristics for melphalan.
Eintrag öffnenColumvi · 4.3 · For specific contraindications on obinutuzumab, please refer to the obinutuzumab prescribing information.
Eintrag öffnenCotellic · 4.8 · Please refer to the vemurafenib SmPC for complete descriptions of all undesirable effects associated with vemu
Eintrag öffnenCotellic · 4.8 · ^ Data cut-off date of 19 September 2014 * Please refer to the paragraph Haemorrhage in the “Description of se
Eintrag öffnenLevemir · 4.8 · The most frequently reported adverse reaction during treatment is hypoglycaemia, please see section 4.8, Descr
Eintrag öffnenLynparza · 4.8 · Patients with significant cardiovascular disease were excluded. Please refer to the product information for ab
Eintrag öffnenMekinist · 4.8 · Pancreatitis has been reported with dabrafenib in combination with trametinib. Please see the dabrafenib SmPC.
Eintrag öffnenMekinist · 4.8 · Renal failure has been reported with dabrafenib in combination with trametinib. Please see the dabrafenib SmPC
Eintrag öffnenOtezla · 4.8 · Please see additional warning in section 4.4 for patients who are underweight at beginning of treatment.
Eintrag öffnenSiiltibcy · 4.8 · #: Please refer to “Description of selected adverse reactions” for further details.
Eintrag öffnenTelmisartan Actavis · 4.8 · 1,2,3,4: for further descriptions, please see sub-section ”Description of selected adverse reactions”.
Eintrag öffnenTelmisartan Teva Pharma · 4.8 · : for further descriptions, please see sub-section ”Description of selected adverse reactions”. 1, 2, 3, 4
Eintrag öffnen